Loading…

Organo Corp.6368.TCompetitor analysis, valuation and peers

Japan · JPY·Industrials›Industrial Machinery

Water treatment engineering company providing ultrapure water systems for semiconductor fabs and industrial water treatment.

≈ Japan's answer to a water-treatment engineering specialist like a smaller Veolia Water TecMomentum laggard 1
Mkt cap
$2.29B
US dollars, full cap
Free float
54%
of shares outstanding
$/day
$21.9M
20-day average traded
Fwd P/E
12.0×
forward earnings
ROIC−WACC
+2.9 pp
WACC 12.7%
Hurdle
+1 pp
Req g minus delivered
Next earnings
77 days
3 Feb 2027
Close · JPY¥1,651
1D-0.3%
1W-8.3%
1M-33.8%
3M-44.2%
6M-54.7%
YTD-36.3%
1Y-40.2%
ATR %7.7%
52w lowhigh59.0% off high

What Organo does

Water treatment engineering company providing ultrapure water systems for semiconductor fabs and industrial water treatment.

Designs and installs water-purification plants for chip fabs and factories, booked as project contracts while plants are built, then keeps earning from maintenance, replacement resins and chemicals, and from running water systems for customers. Fab construction cycles therefore set project revenue, while service income is steadier.

In one line: Japan's answer to a water-treatment engineering specialist like a smaller Veolia Water Tec.

Products and services

  • Ultrapure water systems (semiconductor fabs)
  • Industrial wastewater treatment
  • Water treatment chemicals/resins

Customers

  • Semiconductor fab operators
  • Industrial plant operators

Where it sits in the supply chain

  • Industrial engineering
  • Water treatment systems
  • Ultrapure water, industrial wastewater…

What could go right

  • Semiconductor fab construction boom

What could go wrong

  • Semiconductor capex cyclicality
  • Competition from Kurita Water Industries

Moat: narrow (process know-how, customer qualification). Deep qualification and process know-how in ultrapure water systems critical to chip fabs.

Headquarters: Tokyo, Japan · Founded: 1949 · Employees: 2,658

Named competitors

Organo at a glance

Size Organo (6368.T) is a Japan Industrials company (Industrial Machinery) with a market value of $2.29B, the 452nd largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥1,651 on 18 Nov 2026.

Performance Over six months the shares fell 54.7%, against -27.3% for the median peer and -1.4% for the Japan market (cap-weighted) — lowest of 20 in its peer set.

Growth Revenue grew 10.3% over the last twelve months (peer median +19.1%); the operating margin is 18.7% (peer median 9.1%).

Valuation It trades at 12.0× forward earnings against a peer median of 23.8× (2nd cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 2.9 points above its cost of capital (12.7% WACC).

Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 746368.T 48
Six months, rebased to 100: Organo against the median of its 20 peers (local-currency closes).

Organo financials

Reported figures in JPY; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥190B¥178B¥163B¥150B¥132B
Revenue growth—+9%+9%+14%—
Gross profit¥64.8B¥65.1B¥55.2B¥43.8B¥35.0B
EBITDA¥37.6B¥39.6B¥33.0B¥24.6B¥17.0B
Net income¥26.9B¥28.4B¥24.1B¥17.3B¥11.7B
Free cash flown/a¥11.0B¥26.5B¥20.5B-¥21.2B
Capital expendituren/a¥2.88B¥2.69B¥1.65B¥1.45B
Total debt¥25.7B¥34.6B¥22.7B¥36.7B¥33.2B

Quarterly statements and history in the cockpit →

Organo competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-40%-20%0%+20%0026115631603638AMBERKALMAR000410300503454910JUN30000093010296141353262686324TIMKEN6454MTRS6368.T6-month return →1-month return →
Up and to the right = strong over both horizons. Organo is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%20×40×60×0026115631603638AMBERKALMARMFPJUN3301029614135326324002975TIMKENMTRS6368.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Organo is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%002611603638KALMAR000410MFPJUN330102962686324002975TIMKENMTRS6368.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Organo is the large dot.

Organo competitors and peer comparison

Head to head with its named competitors (6368.T vs 6370.T vs VIE.PA vs ECL)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Organo 6368.T$2.29B-55%+10%19%12.0×12.7%
Kurita Water Industries 6370.T$3.70B-38%0%10%15.2×13.6%
Veolia Environnement VIE.PA$27.4B-3%0%8%14.1×8.6%
Ecolab ECL$84.3B+21%+9%18%33.6×20.3%

How Organo compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Organo against its 20 peers (data as of 18 Nov 2026)
Measure6368.TPeer medianRank in peer set
1-month return-33.8%-4.0%2nd lowest of 21
6-month return-54.7%-27.3%lowest of 20
Distance from 52-week high-59.0%-40.6%2nd lowest of 21
Revenue growth (TTM)+10.3%+19.1%7th lowest of 21
Operating margin18.7%9.1%2nd highest of 21
Forward P/E12.0×23.8×2nd cheapest of 17
Growth the price implies (Req g, 7 yrs)12.7%14.0%6th least demanding of 15
Growth delivered (Del g)+12.0%+9.7%6th highest of 15
Hurdle (Req g minus delivered)+0.6 pp+2.8 pp7th least demanding of 15
ROIC minus cost of capital+2.9 pp+0.3 pp9th highest of 21
EV / EBITDA9.9×14.2×5th cheapest of 13
Net debt / EBITDA0.2×0.2×7th least indebted of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Organo 6368.TJapan$2.29B-55%+10%19%12.0×12.7%+12.0%
Guangdong Dongfang Precision Science & Technology 002611.SZChina$2.28B-30%-16%8%18.4×14.7%+12.4%
Japan Steel Works 5631.TJapan$2.24B-36%-4%10%15.7×n/an/a
Yantai Eddie Precision Machinery 603638.SSChina$2.23B-34%+35%16%27.6×14.1%+7.3%
Amber Enterprises India AMBER.NSIndia$2.35B-13%+24%4%68.8×n/an/a
Kalmar KALMAR.HEFinland$2.22B-12%+7%12%13.6×-4.6%-3.6%
Shenyang Machine Tool 000410.SZChina$2.22B-6%+29%-3%n/a26.5%+22.7%
Guangzhou Haozhi Industrial 300503.SZChina$2.39B-27%+55%20%n/an/an/a
Doosan Robotics 454910.KSSouth Korea$2.39B-53%+97%-91%n/an/an/a
Midera Food Processing MFPUnited States$2.18Bn/a+11%14%18.3×3.5%+10.5%
Jungheinrich AG Pref JUN3.DEGermany$2.40B-13%+2%5%9.8×-1.2%+7.6%
China Baoan 000009.SZChina$2.41B-20%+26%7%n/an/an/a
Dongguan Yiheda Automation 301029.SZChina$2.42B-16%+31%18%24.7×19.9%+19.5%
Dmg Mori 6141.TJapan$2.44B-29%+20%4%22.8×12.7%+9.4%
Formosa Sumco Technology 3532.TWTaiwan$2.44B+4%+16%4%32.5×n/an/a
Nabtesco 6268.TJapan$2.45B-39%+9%9%16.1×6.5%+2.0%
Harmonic Drive Systems 6324.TJapan$2.47B-42%+19%9%58.8×54.4%+10.0%
Zhuhai Bojay Electronics 002975.SZChina$2.12B-40%+71%18%37.9×32.4%+6.0%
Timken India TIMKEN.NSIndia$2.50B-12%+19%16%46.5×36.8%+19.8%
Max 6454.TJapan$2.10B+2%+11%18%20.5×3.8%+9.2%
Munters MTRS.STSweden$2.50B-32%0%9%28.3×13.9%+16.0%

Questions

Who are Organo's main competitors?
Named competitors: Kurita Water Industries (6370.T), Veolia (VIE.PA), Ecolab (ECL). The cockpit's measured peer set (industry) also includes Guangdong Dongfang Precision Science & Technology (002611.SZ), Japan Steel Works (5631.T), Yantai Eddie Precision Machinery (603638.SS), Amber Enterprises India (AMBER.NS), Kalmar (KALMAR.HE), Shenyang Machine Tool (000410.SZ).
Is Organo expensive compared with its peers?
On forward p/e it trades at 12.0× against a peer median of 23.8×, 2nd cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Organo stock performed?
Over six months to 18 Nov 2026 the shares returned -54.7% against -27.3% for the median peer; over one year -40.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.